Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians

Conclusions: The increases in diversion and abuse measures indicate the need to take active attempts to curb diversion and abuse as well as continuous monitoring and surveillance of all buprenorphine products. However, these increases parallel the increased number of tablets sold. Finding a balance of risk/benefit (i.e. diversion and abuse versus expanded treatment) remains a challenge. (Source: Drug and Alcohol Dependence)